Longevity Health (XAGE) shares almost doubled amid heavy trading after the company said late Monday that it will merge with THPlasma in a deal valued up to $79 million.
More than 98 million shares traded intraday compared with a daily average of about 512,000.
Kairos Pharma (KAPA) reported Tuesday positive safety results from an ongoing phase 2 trial of ENV-105 in advanced prostate cancer.
Shares surged 54% as intraday trading volume climbed to more than 226.8 million from a daily average of about 900,000.
Apple (AAPL) has signed a $500 million long-term agreement with MP Materials (MP), the latter said Tuesday.
Under the terms of the partnership, MP Materials will provide Apple with magnets produced at its Fort Worth, Texas, facility using recycled feedstock processed at its Mountain Pass site in California.
Shares of MP advanced 23% as intraday trading volume catapulted to more than 57.5 million from a daily average of about 11.5 million.
Price: 5.22, Change: +2.58, Percent Change: +97.35
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.